- Ironwood Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference
- Ironwood Late-Breaker Oral Presentation at Digestive Disease Week® Reinforces Potential of Once-Weekly Apraglutide for Adults with Short Bowel Syndrome with Intestinal Failure (SBS-IF)
- Ironwood Pharmaceuticals Reports First Quarter 2024 Results
- Ironwood Pharmaceuticals to Participate in The Citizens JMP Life Sciences Conference
- Ironwood Pharmaceuticals to Present New Data on Once-Weekly Apraglutide in Short Bowel Syndrome with Intestinal Failure (SBS-IF) at Digestive Disease Week® 2024
- Ironwood Pharmaceuticals to Host First Quarter 2024 Investor Update Call
More ▼
Key statistics
On Friday, Ironwood Pharmaceuticals Inc (IRWD:NSQ) closed at 6.49, 18.65% above the 52 week low of 5.47 set on Jun 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 6.11 |
---|---|
High | 6.58 |
Low | 6.04 |
Bid | 6.14 |
Offer | 6.56 |
Previous close | 6.11 |
Average volume | 2.77m |
---|---|
Shares outstanding | 158.96m |
Free float | 156.25m |
P/E (TTM) | -- |
Market cap | 1.03bn USD |
EPS (TTM) | -6.79 USD |
Data delayed at least 15 minutes, as of Jul 05 2024 21:00 BST.
More ▼